FDA, Compound and weight loss
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...
Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
Ozempic and its ilk may do a lot of things, but raising the risk of suicide doesn’t appear to be one of them. Research out ...
Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback